Company Description
OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey.
It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events.
The company was founded in 2006 and is based in Waltham, Massachusetts.
| Country | United States |
| Founded | 2006 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 136 |
| CEO | Stephen Silvestro |
Contact Details
Address: 260 Charles Street, Suite 302 Waltham, Massachusetts 02453 United States | |
| Phone | 248-651-6568 |
| Website | optimizerx.com |
Stock Details
| Ticker Symbol | OPRX |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001448431 |
| CUSIP Number | 68401U204 |
| ISIN Number | US68401U2042 |
| Employer ID | 26-1265381 |
| SIC Code | 7389 |
Key Executives
| Name | Position |
|---|---|
| Stephen L. Silvestro | President and Interim Chief Executive Officer |
| Edward Stelmakh C.M.A., M.B.A. | Chief Financial Officer and Chief Operating Officer |
| Andrew Jacob D'Silva | Senior Vice President of Corporate Finance |
| Marion K Odence-Ford | General Counsel and Chief Compliance Officer |
| Maira Alejandra | Media Relations Manager |
| Sheryl Kearney | Human Resources Manager |
| Terence J. Hamilton | Senior Vice President of Pharma |
| Dr. Doug Besch | Chief Product Officer |
| Theresa Greco | Chief Commercial Officer |
| Brian Clark McCarthy | Chief Revenue Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 13, 2025 | SCHEDULE 13G/A | Filing |
| Feb 5, 2025 | SCHEDULE 13D | Filing |
| Jan 28, 2025 | SCHEDULE 13G | Filing |
| Jan 10, 2025 | 8-K | Current Report |
| Jan 8, 2025 | SCHEDULE 13G/A | Filing |
| Dec 23, 2024 | 8-K | Current Report |
| Dec 6, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 14, 2024 | 10-Q | Quarterly Report |
| Nov 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |